Laparoscopic colostomy in gynecologic cancer. [J Minim Invasive Gynecol.

Smoking and the risk of breast cancer in BRCA1 and BRCA 2 carriers: an update (Narod et al)

Treatments of epithelial ovarian cancer by histological subtype

note specific reference to clear cell ovarian cancer international trial

Resistance to Cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity

Canadian Virtual Hospice - ask an expert/information

Cumulative lifetime incidence of extracolonic cancers in Lynch Syndrome: a eport of 121 families with proven mutations

Cumulative risk for females of an extracolonic tumour is 47.4% (95% CI 43.9-50.8). The risk to males is 26.5% (95% CI 22.6-30.4). There was no reduction in gynaecological malignancies due to gynaecological screening (examination, transvaginal ultrasound scan, hysteroscopy and endometrial biopsy).

Pulmonary tumor thrombotic microangiopathy caused by an ovarian cancer expressing tissue factor and VEFG

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial

Lancet Oncology Summary